The rare repurposing open call is now closed to new submissions. We will updating the community about its progress in the coming weeks. Thank you to everyone who got involved.
The rare repurposing open call is a collaborative project between Findacure, Cures Within Reach, and Healx. We are searching for existing drug repurposing ideas for rare diseases that have yet to receive a full clinical trial. Our primary aim is to demonstrate the huge potential of clinic-led, patient group-led, and researcher-driven innovation in drug repurposing for rare diseases, and the need for new funding streams to help these ideas bridge the translational gap, including Findacure’s Rare Disease Drug Repurposing Social impact Bond (RDDR SIB).
From March to the end of May 2017, we asked people around the world to share their repurposing ideas for rare diseases, with the aim of advancing the best of these projects, either through support, or the identification of funding opportunities.
Ideal projects for the call would fit into the RDDR SIB and:
This call did not just aim to identify some suitable projects for the Findacure RDDR SIB project. It also aimed to demonstrate to health care providers, research funders, and the rare disease community that there are a significant number of plausible rare disease repurposing projects held by the research and healthcare professions, and that these are struggling to secure conventional funding.
We held two webinars for those who wanted to find out more about drug repurposing and the open call, you can find links to recordings of these webinars below:
For more information, please contact Findacure’s CEO, Dr Rick Thompson, on [email protected]